UTI Statistics
Total Valuation
UTI has a market cap or net worth of $1.11 billion. The enterprise value is $1.27 billion.
Important Dates
The last earnings date was Wednesday, November 18, 2026, after market close.
| Earnings Date | Nov 18, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
UTI has 55.10 million shares outstanding. The number of shares has increased by 0.34% in one year.
| Current Share Class | 55.10M |
| Shares Outstanding | 55.10M |
| Shares Change (YoY) | +0.34% |
| Shares Change (QoQ) | -0.23% |
| Owned by Insiders (%) | 2.32% |
| Owned by Institutions (%) | 106.47% |
| Float | 53.80M |
Valuation Ratios
The trailing PE ratio is 33.62 and the forward PE ratio is 373.52. UTI's PEG ratio is 24.90.
| PE Ratio | 33.62 |
| Forward PE | 373.52 |
| PS Ratio | 1.24 |
| Forward PS | 1.19 |
| PB Ratio | 3.05 |
| P/TBV Ratio | 3.60 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 11.79 |
| PEG Ratio | 24.90 |
Financial Ratio History Enterprise Valuation
| EV / Earnings | 37.68 |
| EV / Sales | 1.41 |
| EV / EBITDA | 14.72 |
| EV / EBIT | 27.79 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.09, with a Debt / Equity ratio of 0.89.
| Current Ratio | 1.09 |
| Quick Ratio | 0.92 |
| Debt / Equity | 0.89 |
| Debt / EBITDA | 2.09 |
| Debt / FCF | n/a |
| Interest Coverage | 11.58 |
Financial Efficiency
Return on equity (ROE) is 9.70% and return on invested capital (ROIC) is 6.35%.
| Return on Equity (ROE) | 9.70% |
| Return on Assets (ROA) | 3.84% |
| Return on Invested Capital (ROIC) | 6.35% |
| Return on Capital Employed (ROCE) | 6.59% |
| Weighted Average Cost of Capital (WACC) | 8.64% |
| Revenue Per Employee | $218,789 |
| Profits Per Employee | $8,189 |
| Employee Count | 4,100 |
| Asset Turnover | 1.03 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, UTI has paid $12.21 million in taxes.
| Income Tax | 12.21M |
| Effective Tax Rate | 26.67% |
Stock Price Statistics
The stock price has decreased by -30.33% in the last 52 weeks. The beta is 1.21, so UTI's price volatility has been higher than the market average.
| Beta (5Y) | 1.21 |
| 52-Week Price Change | -30.33% |
| 50-Day Moving Average | 20.93 |
| 200-Day Moving Average | 31.88 |
| Relative Strength Index (RSI) | 41.89 |
| Average Volume (20 Days) | 1,543,173 |
Short Selling Information
The latest short interest is 7.69 million, so 13.96% of the outstanding shares have been sold short.
| Short Interest | 7.69M |
| Short Previous Month | 6.93M |
| Short % of Shares Out | 13.96% |
| Short % of Float | 14.30% |
| Short Ratio (days to cover) | 5.55 |
Income Statement
In the last 12 months, UTI had revenue of $897.04 million and earned $33.58 million in profits. Earnings per share was $0.60.
| Revenue | 897.04M |
| Gross Profit | 426.74M |
| Operating Income | 45.54M |
| Pretax Income | 45.79M |
| Net Income | 33.58M |
| EBITDA | 85.94M |
| EBIT | 45.54M |
| Earnings Per Share (EPS) | $0.60 |
Full Income Statement Balance Sheet
The company has $170.78 million in cash and $324.70 million in debt, with a net cash position of -$153.92 million or -$2.79 per share.
| Cash & Cash Equivalents | 170.78M |
| Total Debt | 324.70M |
| Net Cash | -153.92M |
| Net Cash Per Share | -$2.79 |
| Equity (Book Value) | 364.14M |
| Book Value Per Share | 6.61 |
| Working Capital | 20.37M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was $94.23 million and capital expenditures -$106.43 million, giving a free cash flow of -$12.20 million.
| Operating Cash Flow | 94.23M |
| Capital Expenditures | -106.43M |
| Depreciation & Amortization | 40.40M |
| Net Borrowing | 27.14M |
| Free Cash Flow | -12.20M |
| FCF Per Share | -$0.22 |
Full Cash Flow Statement Margins
Gross margin is 47.57%, with operating and profit margins of 5.08% and 3.74%.
| Gross Margin | 47.57% |
| Operating Margin | 5.08% |
| Pretax Margin | 5.10% |
| Profit Margin | 3.74% |
| EBITDA Margin | 9.58% |
| EBIT Margin | 5.08% |
| FCF Margin | n/a |
Dividends & Yields
UTI does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -0.34% |
| Shareholder Yield | -0.34% |
| Earnings Yield | 2.97% |
| FCF Yield | -1.10% |
Dividend Details Analyst Forecast
The average price target for UTI is $32.33, which is 60.29% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $32.33 |
| Price Target Difference | 60.29% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 6 |
| Revenue Growth Forecast (3Y) | 9.42% |
| EPS Growth Forecast (3Y) | n/a |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |
| Graham Formula Value | |
| Graham Formula Upside | |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
UTI has an Altman Z-Score of 3.26 and a Piotroski F-Score of 5.
| Altman Z-Score | 3.26 |
| Piotroski F-Score | 5 |